[Can one avoid a hepatic biopsy in the management of diffuse diseases of the liver?].
Pelletier
Gilles
G
D001707:Biopsy, Needle / Q000009:adverse effects; D002648:Child; D003937:Diagnosis, Differential; D006432:Hemochromatosis / Q000175:diagnosis / Q000473:pathology; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D006801:Humans; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008107:Liver Diseases / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy; D008108:Liver Diseases, Alcoholic / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D010342:Patient Acceptance of Health Care; D011379:Prognosis; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity